Freenome Establishes Interim Office of the CEO with Riley Ennis, Co-founder, Taking Lead Role
Company
Freenome
BrisbaneBiotechnologyHealth CareScience And EngineeringVenture CapitalLife ScienceDescription
Mike Nolan has resigned as chief executive officer (CEO) of Freenome for personal reasons. The Board of Directors has established an interim Office of the CEO, led by Freenome's co-founder Riley Ennis, with assistance from Douglas VanOort, a Freenome Board member and former chairman of the board and CEO at NeoGenomics, to provide leadership continuity and operational management during the transition. The board will be selecting a successor to guide the organization toward commercialization and increasing its public presence as Freenome focuses on bringing blood-based screening to patients.
Quick answer
Freenome Establishes Interim Office of the CEO with Riley Ennis, Co-founder, Taking Lead Role (September 25, 2024). Freenome is based in Brisbane, California, United States.
- What did Freenome announce on September 25, 2024?
- Mike Nolan has resigned as chief executive officer (CEO) of Freenome for personal reasons. The Board of Directors has established an interim Office of the CEO, led by Freenome's co-founder Riley Ennis, with assistance from Douglas VanOort, a Freenome Board member and former chairman of the board and CEO at NeoGenomics, to provide leadership continuity and operational management during the transition.
- What does Freenome do?
- Freenome is a biotechnology company with a comprehensive multiomics platform for early cancer detection using a routine blood draw.
- Where is Freenome based?
- Freenome is based in Brisbane, California, United States.
- Which similar companies made leadership changes around the same time?
- Nautilus Biotechnology (September 18, 2024), Ray Therapeutics (September 16, 2024), Wheeler Bio (October 9, 2024) and Abalos (October 9, 2024) also announced leadership changes within 45 days of Freenome.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Venture Capital
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Nautilus Biotechnology Appoints Ken Suzuki as Chief Marketing Officer (September 18, 2024)
- Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer (September 16, 2024)
- Wheeler Bio Appoints Patrick Lucy as Chief Executive Officer (October 9, 2024)
- Abalos Therapeutics Appoints Gerben Moolhuizen as Chief Executive Officer (October 9, 2024)
- HAYA Therapeutics Appoints Jordan Shin as Chief Medical Officer (CMO) (September 11, 2024)
- Unlearn Appoints Steve Herne as CEO, Charles Fisher as Chief Scientist (September 11, 2024)
Who to call at Freenome, and when
A new leader at Freenome brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Freenome raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Freenome, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Freenome. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Freenome changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Freenome changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.